RAF remains liable for medical expenses paid by schemes, SCA rules
The Court found that two later directives were issued as part of a ‘contrived stratagem’ to circumvent a binding judgment.
#medicalschemes
Complaints against medical schemes rise by 24.6%
The CMS’s 2025/26 annual report also highlights progress on a costed primary healthcare benefits package and research into linking administrator fees to outcomes.
Sizwe Hosmed enters 2027 with 40% solvency and self-administration in place
Contributions will increase by between 7.5% and 8.5%, with Essential Copper introducing a lower-income band.
Bonitas raises contributions by 8.7% as new service model takes shape
Four months after a troubled administrator switch, Bonitas is betting on new products, tighter managed care, and a stronger digital offering to rebuild member value and trust.
Discovery Health’s 2027 plans: 8.2% average increase and a new option
Two out of three beneficiaries will face increases below 8%, while Discovery is adding a new lower-cost plan and expanding its personalised health platform.
Medihelp sets 7.5% weighted average increase for 2027
Most members will face increases of 7% or less, while the scheme is adding benefits in mental health, maternity, preventive care, and emergency treatment.
Momentum Medical Scheme to raise contributions by 7.9%
The scheme is pairing the increase with changes to Health4Me and a broader push into prevention, wellness, and digital healthcare.
Bestmed sets 2027 contributions to increase by 7.35%
The scheme is adding a R1 000 healthcare benefit, expanding preventative care, and making targeted changes to medicine, casualty, and clinical cover.
BHF: CMS’s contribution guidance could create unrealistic expectations
The industry body says the 3.8% benchmark does not fully reflect the utilisation and underlying healthcare-cost pressures that schemes face.
Global medical cost growth is cooling. Why isn’t South Africa’s?
Global medical cost growth is easing, but South Africa’s rate remains high – putting medical schemes under pressure to balance rising healthcare costs with affordability in 2027.
GEMS faces scrutiny over costs, governance, and reserves
Parliamentary questions extend from fraud and outsourcing to trustee remuneration and benefit design, while the scheme’s reserves remain below the statutory requirement.
GEMS suspension puts governance under scrutiny
DENOSA says the lack of disclosure over Stan Moloabi’s suspension raises wider questions about the scheme’s leadership, accountability, and handling of member concerns.
Bonitas transition stabilises, but providers still face problems
Operational improvements have reduced the disruption, but short-paid and unpaid claims, tariff discrepancies, and difficult authorisations continue to require attention.
Has the NHI debate reached a turning point?
Discovery believes the legal challenges have shifted government’s thinking on NHI and created an opportunity to pursue a more workable path to universal health coverage.
Bonitas defends administrator switch after record financial results
Executives acknowledged the disruption caused by the June administrator switch while insisting the scheme’s long-term strategy remains on track.
When it’s your money, who should decide?
As employers hand more responsibility for retirement and healthcare benefits to staff, the industry is rethinking how to balance freedom with better financial decisions.
CMS sets end-August target for Bonitas procurement investigation
The regulator has clarified the scope of its oversight of Bonitas, confirming that two separate regulatory processes are under way.
